We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

136 hedge funds and large institutions have $2.38B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

23,455% more call options, than puts

Call options by funds: $1.26B | Put options by funds: $5.36M

407% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 14

110% more capital invested

Capital invested by funds: $1.13B → $2.38B (+$1.25B)

70% more funds holding

Funds holding: 80136 (+56)

56% more funds holding in top 10

Funds holding in top 10: 914 (+5)

45% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 22

1.9% more ownership

Funds ownership: 14.09%15.99% (+1.9%)

Holders
136
Holders Change
+56
Holders Change %
+70%
% of All Funds
2.37%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.24%
New
71
Increased
32
Reduced
22
Closed
14
Calls
$1.26B
Puts
$5.36M
Net Calls
+$1.26B
Net Calls Change
+$1.26B
Name Holding Trade Value Shares
Change
Change in
Stake
JF
101
Jump Financial
Illinois
$456K +$359K +5,438 New
PAM
102
Panagora Asset Management
Massachusetts
$445K +$349K +5,295 New
BFM
103
Boothbay Fund Management
New York
$428K -$1.64M -24,867 -83%
SAM
104
Storebrand Asset Management
Norway
$417K +$327K +4,962 New
Aberdeen Group
105
Aberdeen Group
United Kingdom
$394K +$309K +4,688 New
AIMCA
106
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$344K +$270K +4,100 New
SEC
107
Seven Eight Capital
New York
$344K +$270K +4,100 New
MWNA
108
Marshall Wace North America
New York
$343K +$269K +4,076 New
VF
109
Virtu Financial
New York
$329K +$259K +3,920 New
Nomura Holdings
110
Nomura Holdings
Japan
$323K +$264K +4,000 New
VOYA Investment Management
111
VOYA Investment Management
Georgia
$298K +$234K +3,544 New
Mirae Asset Global Investments
112
Mirae Asset Global Investments
South Korea
$297K +$233K +3,530 New
ED
113
Exane Derivatives
France
$287K
VEA
114
Virtus ETF Advisers
New York
$259K -$315K -4,774 -61%
APG Asset Management
115
APG Asset Management
Netherlands
$241K +$224K +3,400 New
Ensign Peak Advisors
116
Ensign Peak Advisors
Utah
$227K +$178K +2,700 New
American Century Companies
117
American Century Companies
Missouri
$213K +$167K +2,535 New
OPS
118
Orion Portfolio Solutions
Nebraska
$212K +$167K +2,525 New
Macquarie Group
119
Macquarie Group
Australia
$190K +$149K +2,261 New
QT
120
Quantbot Technologies
New York
$151K +$119K +1,800 New
Royal Bank of Canada
121
Royal Bank of Canada
Ontario, Canada
$137K +$66 +1 +0.1%
LSA
122
Leonteq Securities AG
Switzerland
$135K
Lazard Asset Management
123
Lazard Asset Management
New York
$128K +$101K +1,531 New
TRCT
124
Tower Research Capital (TRC)
New York
$69K +$8.31K +126 +18%
PCM
125
Penserra Capital Management
California
$60K +$20.1K +305 +73%

NBP Hedge Fund Activity: Q2 2021 in Review

136 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2021, worth a combined $2.38B — up 110% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new NBP positions and 14 closed out — a net gain of 57 holders — while 32 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $108M. The largest seller was Avidity Partners Management, cutting an estimated $39.6M.

  • 136 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2021, up from 80 in Q1 2021.
  • Funds reported $2.38B of NovaBridge Biosciences American Depositary Shares stock for Q2 2021, up 110% quarter-over-quarter.
  • 71 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2021 and 14 closed out, a net change of +57 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2021 was BlackRock, an estimated $108M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2021 was Avidity Partners Management, an estimated $39.6M sold.

Based on aggregated 13F filings for Q2 2021.